Literature DB >> 29316278

Integrated Approaches to Testing and Assessment: OECD Activities on the Development and Use of Adverse Outcome Pathways and Case Studies.

Yuki Sakuratani1, Masashi Horie1, Eeva Leinala1.   

Abstract

The Organisation for Economic Co-operation and Development (OECD) works with member countries and other stakeholders to improve and harmonize chemical assessment methods. In 2012, the OECD Adverse Outcome Pathways (AOPs) Development Programme started. The Programme has published six AOPs thus far and more than 60 AOPs are under various stages of development under the Programme. This article reviews recent OECD activities on the use of AOPs in developing Integrated Approaches to Testing and Assessments (IATAs). The guidance document for the use of AOPs in developing IATA, published in 2016, provides a framework for developing and using IATA and describes how IATA can be based on an AOP. The guidance document on the reporting of defined approaches to be used within IATA, also published in 2016, provides a set of principles for reporting defined approaches to testing and assessment to facilitate their evaluation. In the guidance documents, the AOP concept plays an important role for building IATA approaches in a science-based and transparent way. In 2015, the IATA Case Studies Project was launched to increase experience with the use of IATA and novel hazard methodologies by developing case studies, which constitute examples of predictions that are fit-for-regulatory use. This activity highlights the importance of international collaboration for harmonizing and improving chemical safety assessment methods.
© 2018 Nordic Association for the Publication of BCPT (former Nordic Pharmacological Society).

Mesh:

Year:  2018        PMID: 29316278     DOI: 10.1111/bcpt.12955

Source DB:  PubMed          Journal:  Basic Clin Pharmacol Toxicol        ISSN: 1742-7835            Impact factor:   4.080


  15 in total

1.  Integration of epidemiological findings with mechanistic evidence in regulatory pesticide risk assessment: EFSA experiences.

Authors:  Olavi Pelkonen; Susanne H Bennekou; Federica Crivellente; Andrea Terron; Antonio F Hernandez
Journal:  Arch Toxicol       Date:  2019-05-03       Impact factor: 5.153

2.  Evaluation of Existing QSAR Models and Structural Alerts and Development of New Ensemble Models for Genotoxicity Using a Newly Compiled Experimental Dataset.

Authors:  Prachi Pradeep; Richard Judson; David M DeMarini; Nagalakshmi Keshava; Todd M Martin; Jeffry Dean; Catherine F Gibbons; Anita Simha; Sarah H Warren; Maureen R Gwinn; Grace Patlewicz
Journal:  Comput Toxicol       Date:  2021-05-01

3.  Current status and future directions for a neurotoxicity hazard assessment framework that integrates in silico approaches.

Authors:  Kevin M Crofton; Arianna Bassan; Mamta Behl; Yaroslav G Chushak; Ellen Fritsche; Jeffery M Gearhart; Mary Sue Marty; Moiz Mumtaz; Manuela Pavan; Patricia Ruiz; Magdalini Sachana; Rajamani Selvam; Timothy J Shafer; Lidiya Stavitskaya; David T Szabo; Steven T Szabo; Raymond R Tice; Dan Wilson; David Woolley; Glenn J Myatt
Journal:  Comput Toxicol       Date:  2022-03-17

4.  Mapping Adverse Outcome Pathways for Kidney Injury as a Basis for the Development of Mechanism-Based Animal-Sparing Approaches to Assessment of Nephrotoxicity.

Authors:  Angela Mally; Sebastian Jarzina
Journal:  Front Toxicol       Date:  2022-06-15

Review 5.  In silico toxicology: From structure-activity relationships towards deep learning and adverse outcome pathways.

Authors:  Jennifer Hemmerich; Gerhard F Ecker
Journal:  Wiley Interdiscip Rev Comput Mol Sci       Date:  2020-03-31

Review 6.  Use cases, best practice and reporting standards for metabolomics in regulatory toxicology.

Authors:  Mark R Viant; Timothy M D Ebbels; Richard D Beger; Drew R Ekman; David J T Epps; Hennicke Kamp; Pim E G Leonards; George D Loizou; James I MacRae; Bennard van Ravenzwaay; Philippe Rocca-Serra; Reza M Salek; Tilmann Walk; Ralf J M Weber
Journal:  Nat Commun       Date:  2019-07-10       Impact factor: 17.694

7.  Deciphering Adverse Outcome Pathway Network Linked to Bisphenol F Using Text Mining and Systems Toxicology Approaches.

Authors:  Marylène Rugard; Xavier Coumoul; Jean-Charles Carvaillo; Robert Barouki; Karine Audouze
Journal:  Toxicol Sci       Date:  2020-01-01       Impact factor: 4.849

8.  Systematic Organization of COVID-19 Data Supported by the Adverse Outcome Pathway Framework.

Authors:  Penny Nymark; Magdalini Sachana; Sofia Batista Leite; Jukka Sund; Catharine E Krebs; Kristie Sullivan; Stephen Edwards; Laura Viviani; Catherine Willett; Brigitte Landesmann; Clemens Wittwehr
Journal:  Front Public Health       Date:  2021-05-19

9.  The 2021 update of the EPA's adverse outcome pathway database.

Authors:  Holly M Mortensen; Jonathan Senn; Trevor Levey; Phillip Langley; Antony J Williams
Journal:  Sci Data       Date:  2021-07-12       Impact factor: 6.444

Review 10.  Bridging the Data Gap From in vitro Toxicity Testing to Chemical Safety Assessment Through Computational Modeling.

Authors:  Qiang Zhang; Jin Li; Alistair Middleton; Sudin Bhattacharya; Rory B Conolly
Journal:  Front Public Health       Date:  2018-09-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.